News

Justin Schleede reaches onto a black lab bench to pick up a tray of small plastic tubes.

"These are saliva samples as well as blood," says Schleede, a geneticist who runs Herasight Inc.'s lab in Morrisville, N.C. "We also...

This is the 15th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. You can read the first part here. The series...

"If proven to be safe, we believe preventive gene editing could be one of the most important health technologies of...

WILLIAM BATESON, a foundational figure in the science of genetics at the turn of the last century, once recounted the...

doctor's coat
By Lindsey Tanner, AP News | 05.11.2021

The nation’s largest doctors group Tuesday released a comprehensive plan aimed at dismantling structural racism inside its own ranks and...

By Editors, Hastings Center Report | 05.10.2021

Genetic tests claiming to predict people’s intellectual aptitudes or how much education they are likely to get are readily available...

eugenics tree
By Douglas Perry, The Oregonian | 05.10.2021

Bethenia Owens-Adair overcame a wave of hardships early in her life to earn a medical degree and become one of...

Trump on sign in bicycle basket
By Lester Golden, Medium | 05.10.2021

When people repeatedly announce who they are in their own words, listen. The core of Nazi ideology is racial darwinism...

dna in syringe
By Wynne Parry, Philadelphia | 05.08.2021

Think back to last spring. (You probably don’t want to, but humor me.) Those early months of the coronavirus pandemic...

dna editing with tweezers (CRISPR depiction)
By Amy Dockser Marcus, The Wall Street Journal | 05.07.2021

At the age of 38, Katherine Wilemon suffered a heart attack as she carried a ceramic pot into her backyard...

ferrets
By Hannah Thomasy, NEO.LIFE | 05.06.2021

On December 10, 2020, Elizabeth Ann made history just by being born. She isn’t a British royal, an American married...

dna
By Diana Kwon, Nature | 05.05.2021

Two pharmaceutical companies have halted clinical trials of gene-targeting therapies for Huntington’s disease (HD), following the drugs’ disappointing performance.

Researchers...